264 related articles for article (PubMed ID: 19101554)
1. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
2. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting.
Shiraki T; Kodama TS; Shiki S; Nakagawa T; Jingami H
Biochem J; 2006 Feb; 393(Pt 3):749-55. PubMed ID: 16236024
[TBL] [Abstract][Full Text] [Related]
4. Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.
Zorrilla S; Garzón B; Pérez-Sala D
Anal Biochem; 2010 Apr; 399(1):84-92. PubMed ID: 20025845
[TBL] [Abstract][Full Text] [Related]
5. Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma.
Soares AF; Nosjean O; Cozzone D; D'Orazio D; Becchi M; Guichardant M; Ferry G; Boutin JA; Lagarde M; Géloën A
Biochem Biophys Res Commun; 2005 Nov; 337(2):521-5. PubMed ID: 16198309
[TBL] [Abstract][Full Text] [Related]
6. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2.
Usui S; Suzuki T; Hattori Y; Etoh K; Fujieda H; Nishizuka M; Imagawa M; Nakagawa H; Kohda K; Miyata N
Bioorg Med Chem Lett; 2005 Mar; 15(6):1547-51. PubMed ID: 15745794
[TBL] [Abstract][Full Text] [Related]
9. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.
Kim EH; Surh YJ
Biochem Pharmacol; 2008 Dec; 76(11):1544-53. PubMed ID: 18771658
[TBL] [Abstract][Full Text] [Related]
10. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads.
Maekawa N; Hiramoto M; Sakamoto S; Azuma M; Ito T; Ikeda M; Naitou M; Acharya HP; Kobayashi Y; Suematsu M; Handa H; Imai T
Biomed Chromatogr; 2011 Apr; 25(4):466-71. PubMed ID: 21374648
[TBL] [Abstract][Full Text] [Related]
11. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
Shiraki T; Kodama TS; Jingami H; Kamiya N
Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
Kim EH; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
14. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H
Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
16. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
Monroy MA; Opperman KK; Pucciarelli M; Yerrum S; Berg DA; Daly JM
Shock; 2007 Aug; 28(2):186-91. PubMed ID: 17510607
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
Olmos G; Conde I; Arenas I; Del Peso L; Castellanos C; Landazuri MO; Lucio-Cazana J
Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243
[TBL] [Abstract][Full Text] [Related]
18. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
20. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
